Advertisement
Advertisement
U.S. markets open in 7 hours 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

LogicBio Therapeutics, Inc. (LOGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9250+0.0250 (+0.64%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close3.9000
Open3.8800
Bid0.0000 x 800
Ask0.0000 x 900
Day's Range3.8600 - 4.0164
52 Week Range3.7200 - 9.7400
Volume57,937
Avg. Volume85,396
Market Cap126.543M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)-1.2000
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LOGC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • LogicBio Therapeutics, Inc.
    QURE: Raising target price to $34.00UNIQURE NV has an Investment Rating of BUY; a target price of $34.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    12 days agoArgus Research
View more
Advertisement
Advertisement